Overview
Portfolio
More
Tabularasa
New York, United States
Invests in pre‑seed and seed‑stage companies developing evidence‑based therapeutic interventions, robust healthcare infrastructure, and cutting‑edge medical technologies, with a focus on holistic, preventative, personali...
Portfolio
12+
Employees
10+
Founded
2019
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Tabularasa
Invests in pre‑seed and seed‑stage companies developing evidence‑based therapeutic interventions, robust healthcare infrastructure, and cutting‑edge medical technologies, with a focus on holistic, preventative, personalized, and democratized human health.
Portfolio
12+
Employees
10+
Founded
2019
AUM
N/A
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Showing 12 of 12 matched portfolio companies
2A Biosciences develops small molecule drugs targeting inflammation through the use of 2A agonists. The company focuses on addressing the unmet medical needs associated with inflammatory diseases by enhancing the therapeutic efficacy of these compounds.
Funding: $3.8M
Rough estimate of the amount of funding raised
Funding: $3.8M
Rough estimate of the amount of funding raised
Apollo is an automated cybersecurity platform that provides tools for security policy generation, vulnerability scanning, and compliance tracking to help startups meet regulatory requirements. The platform addresses the challenge of maintaining security compliance by streamlining risk management and evidence collection processes, enabling businesses to protect their IT assets effectively.
Funding: $383.0K
Rough estimate of the amount of funding raised
Brisbane AngelsSydney Angels
Brisbane AngelsSydney Angels
Funding: $383.0K
Rough estimate of the amount of funding raised
This platform connects patients with clinics offering FDA-approved, insurance-covered treatments for depression, OCD, PTSD, and anxiety. It enables patients to access breakthrough mental health therapies, including at-home options, while helping clinics integrate these treatments with insurance billing.
<3
300+Approximate amount of employees
DeepWell DTx combines FDA-cleared biofeedback technology with interactive gaming to provide over-the-counter digital therapeutics that target stress and hypertension. Their first game, Zengence, utilizes vocal meditation techniques to enhance vagus nerve activation, promoting resilience and reducing anxiety in players.
Enthea operates as a third-party administrator specializing in employer-sponsored mental health benefits. The company integrates advanced, evidence-based therapies such as Ketamine-Assisted Therapy (KAT) and Stellate Ganglion Block (SGB) into existing benefits plans. This turnkey solution provides employees access to root-cause treatments, aiming for measurable ROI through reduced symptoms, lower claims, and improved retention.
Tabula Rasa Ventures
Lykos Therapeutics develops investigational psychedelic compounds and provides therapist training programs to enhance treatment options for mental health conditions, particularly PTSD. By focusing on evidence-based research, the company aims to create safe and effective prescription psychedelic therapies that can be integrated into the healthcare system.
Funding: $100.0M
Rough estimate of the amount of funding raised
Helena
Helena
Funding: $100.0M
Rough estimate of the amount of funding raised
<name>Olden Labs</name>
<description>Olden Labs provides DOME Smart lids that enable continuous, non‑invasive home‑cage monitoring of laboratory animals. The system captures over 20 digital biomarkers, offers multi‑animal tracking without RFID, and delivers real‑time alerts for health, welfare, and experimental parameters. Integration with existing rack systems is fast, low‑cost, and reduces labor while improving data quality and reproducibility.</description
Psynautics is a research platform that employs data analytics and machine learning to analyze complex datasets in neuroscience and pharmacology. The platform enables researchers to gain insights into brain function and the impact of various substances on consciousness, enhancing the understanding of these critical areas.
RA UNLIMITED harnesses solar photovoltaic technology to generate clean and affordable electricity for homes, businesses, and communities in the Philippines. The company addresses the reliance on fossil fuels by providing sustainable energy solutions that create jobs and enhance the quality of life for Filipinos.
Terran Biosciences builds next‑generation neuropsychiatric medicines using prodrug technology, selective 5‑HT2A antagonists, and AI‑driven drug design to create once‑daily oral and long‑acting injectable treatments for schizophrenia and related disorders. It also develops fixed‑dose psychedelic combinations and GMP‑manufactured psychoplastogens, offering pharmaceutical partners and treatment centers advanced therapeutic options.
Funding: $113.2M
Rough estimate of the amount of funding raised
Funding: $113.2M
Rough estimate of the amount of funding raised
Thesis formulates personalized nootropic blends based on individual brain chemistry and cognitive goals, utilizing clinically studied ingredients to enhance mental performance. The company addresses issues such as lack of focus, low energy, and motivation by providing tailored supplements that improve cognitive function and overall mental clarity.
Funding: $27.1M
Rough estimate of the amount of funding raised
Funding: $27.1M
Rough estimate of the amount of funding raised
Wavepaths creates digital audio tools designed for psychedelic therapy, enabling users to engage in guided inner exploration and personal transformation. These tools provide accessible therapeutic resources that enhance mental health and well-being during psychedelic sessions.
Funding: $4.5M
Rough estimate of the amount of funding raised
Funding: $4.5M
Rough estimate of the amount of funding raised